GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Starling Oncology, Inc. (STLN) | 11/6/2026 6:19:06 AM | Small | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Rev: $169,767,000 +24.3% | Assets $187,773,000 | EPS -$0.13 | |
| Starling Oncology, Inc. (STLN) | 11/5/2026 5:02:03 PM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $169,767,000 +24.3% | Assets $187,773,000 | EPS -$0.13 | Export Earnings Model | |
| Starling Oncology, Inc. (STLN) | 8/6/2026 4:57:52 PM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $161,282,000 +34.6% | Assets $178,233,000 | EPS -$0.08 | |
| Starling Oncology, Inc. (STLN) | 8/6/2026 4:53:45 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $161,282,000 +34.6% | Assets $178,233,000 | EPS -$0.08 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 5/8/2026 4:02:07 AM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $147,441,000 +41.2% | Assets $168,230,000 | EPS -$0.02 | |
| Oncology Institute, Inc. (STLN) | 5/7/2026 4:19:53 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $147,441,000 +41.2% | Assets $168,230,000 | EPS -$0.02 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 4/30/2026 6:41:14 PM | View | Proxy | SEC | Y 2025 | ||||||
| Oncology Institute, Inc. (STLN) | 3/12/2026 5:01:25 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $502,729,000 +27.8% | Assets $164,656,000 | EPS -$0.54 | |
| Oncology Institute, Inc. (STLN) | 3/12/2026 4:08:08 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $141,957,000 +41.6% | Assets $164,656,000 | EPS -$0.05 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 1/12/2026 8:02:45 AM | View | Financials | Earnings (Prelim) | SEC | Y 2025 | Export Earnings Model | ||||
| Oncology Institute, Inc. (STLN) | 11/13/2025 4:25:13 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $136,564,000 +36.7% | Assets $163,619,000 | EPS -$0.14 | |
| Oncology Institute, Inc. (STLN) | 11/13/2025 4:09:08 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $136,564,000 +36.7% | Assets $163,619,000 | EPS -$0.14 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 8/13/2025 5:25:35 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $119,802,000 +21.5% | Assets $159,798,000 | EPS -$0.15 | |
| Oncology Institute, Inc. (STLN) | 8/13/2025 4:26:59 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $119,802,000 +21.5% | Assets $159,798,000 | EPS -$0.15 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 5/14/2025 4:33:42 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $104,406,000 +10.3% | Assets $164,002,000 | EPS -$0.21 | |
| Oncology Institute, Inc. (STLN) | 5/14/2025 4:28:37 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $104,406,000 +10.3% | Assets $164,002,000 | EPS -$0.21 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 3/27/2025 6:07:49 AM | View | Proxy | SEC | Y 2024 | ||||||
| Oncology Institute, Inc. (STLN) | 3/26/2025 6:13:59 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $393,412,000 +21.3% | Assets $172,717,000 | EPS -$0.71 | |
| Oncology Institute, Inc. (STLN) | 3/24/2025 7:00:57 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $100,267,000 +16.9% | Assets $172,717,000 | EPS -$0.15 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 11/13/2024 4:43:14 PM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $99,901,000 +21.8% | Assets $179,183,000 | EPS -$0.18 | |
| Oncology Institute, Inc. (STLN) | 11/13/2024 4:09:42 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $99,901,000 +21.8% | Assets $179,183,000 | EPS -$0.18 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 8/13/2024 4:29:44 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $98,578,000 +22.9% | Assets $179,602,000 | EPS -$0.17 | |
| Oncology Institute, Inc. (STLN) | 8/13/2024 4:07:49 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $98,578,000 +22.9% | Assets $179,602,000 | EPS -$0.17 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 5/22/2024 4:28:50 PM | Small | View | Financials | 10-Q/A | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $94,666,000 +24.2% | Assets $204,532,000 | EPS -$0.22 | |
| Oncology Institute, Inc. (STLN) | 5/22/2024 4:18:48 PM | Small | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $324,239,000 +28.4% | Assets $209,240,000 | EPS -$0.92 | |
| Oncology Institute, Inc. (STLN) | 5/14/2024 4:38:21 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $94,666,000 +24.2% | Assets $204,532,000 | EPS -$0.22 | |
| Oncology Institute, Inc. (STLN) | 5/14/2024 4:04:40 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $94,666,000 +24.2% | Assets $204,532,000 | EPS -$0.22 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 5/2/2024 4:57:04 PM | View | Proxy | SEC | Y 2023 | ||||||
| Oncology Institute, Inc. (STLN) | 4/22/2024 4:47:19 PM | Small | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $324,239,000 +28.4% | Assets $209,240,000 | EPS -$0.92 | |
| Oncology Institute, Inc. (STLN) | 4/3/2024 4:02:18 PM | View | Presentation | SEC | 2Q 2024 | ||||||
| Oncology Institute, Inc. (STLN) | 3/28/2024 6:56:15 AM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $324,239,000 +28.4% | Assets $209,240,000 | EPS -$0.92 | |
| Oncology Institute, Inc. (STLN) | 3/27/2024 4:11:01 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $85,788,000 +20.1% | Assets $209,240,000 | EPS -$0.21 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 11/8/2023 4:55:30 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $82,035,000 +26.3% | Assets $218,353,000 | EPS -$0.19 | |
| Oncology Institute, Inc. (STLN) | 11/8/2023 4:42:06 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $82,035,000 +26.3% | Assets $218,353,000 | EPS -$0.19 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 8/10/2023 5:17:28 PM | View | Presentation | SEC | 3Q 2023 | ||||||
| Oncology Institute, Inc. (STLN) | 8/9/2023 4:39:51 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $80,224,000 +31.7% | Assets $229,959,000 | EPS -$0.19 | |
| Oncology Institute, Inc. (STLN) | 8/9/2023 6:05:03 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $80,224,000 +31.7% | Assets $229,959,000 | EPS -$0.19 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 5/10/2023 4:20:54 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $76,192,000 +38.1% | Assets $234,633,000 | EPS -$0.33 | |
| Oncology Institute, Inc. (STLN) | 5/10/2023 4:18:39 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $76,192,000 +38.1% | Assets $234,633,000 | EPS -$0.33 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 4/28/2023 4:58:38 PM | View | Proxy | SEC | Y 2022 | ||||||
| Oncology Institute, Inc. (STLN) | 3/27/2023 5:27:56 PM | View | Presentation | SEC | 1Q 2023 | ||||||
| Oncology Institute, Inc. (STLN) | 3/17/2023 6:02:29 AM | View | Correction | SEC | Y 2022 | ||||||
| Oncology Institute, Inc. (STLN) | 3/16/2023 4:38:01 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $252,483,000 +24.4% | Assets $261,665,000 | EPS -$0.21 | |
| Oncology Institute, Inc. (STLN) | 3/9/2023 4:23:03 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $71,424,000 +36.6% | Assets $261,665,000 | EPS -$0.18 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 11/15/2022 6:21:55 AM | View | Presentation | SEC | Y 2022 | ||||||
| Oncology Institute, Inc. (STLN) | 11/9/2022 4:35:21 PM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $64,977,000 +24.3% | Assets $283,802,000 | EPS -$0.17 | |
| Oncology Institute, Inc. (STLN) | 11/9/2022 4:09:01 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $64,977,000 +24.3% | Assets $283,802,000 | EPS -$0.17 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 8/16/2022 6:10:37 AM | View | Presentation | SEC | 3Q 2022 | ||||||
| Oncology Institute, Inc. (STLN) | 8/11/2022 4:04:24 AM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $60,921,000 +22.2% | Assets $189,740,000 | EPS -$0.06 | |
| Oncology Institute, Inc. (STLN) | 8/9/2022 8:56:00 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $60,921,000 +22.2% | Assets $189,740,000 | EPS -$0.06 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 6/3/2022 9:02:32 AM | View | Proxy | SEC | Y 2021 | ||||||
| Oncology Institute, Inc. (STLN) | 5/11/2022 6:08:12 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $55,161,000 +13.5% | Assets $206,512,000 | EPS $0.21 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 5/10/2022 5:40:36 PM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $55,161,000 +13.5% | Assets $206,512,000 | EPS $0.21 | |
| Oncology Institute, Inc. (STLN) | 3/11/2022 4:13:28 PM | View | Presentation | SEC | 1Q 2022 | ||||||
| Oncology Institute, Inc. (STLN) | 3/11/2022 3:41:43 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $203,003,000 | Assets $203,439,000 | EPS -$0.16 | |
| Oncology Institute, Inc. (STLN) | 3/10/2022 4:11:13 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $52,304,000 | Assets $203,439,000 | EPS -$0.15 | Export Earnings Model | |
| Oncology Institute, Inc. (STLN) | 12/14/2021 6:11:19 AM | Small | View | Financials | 10-Q/A | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $52,275,000 | Assets $230,299,733 | EPS -$0.05 | |
| Oncology Institute, Inc. (STLN) | 12/14/2021 6:11:18 AM | Micro | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Assets $65,689,000 | EPS -$0.24 | ||
| DFP HEALTHCARE ACQUISITIONS CORP. (STLN) | 11/8/2021 5:23:02 PM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $52,275,000 | Assets $230,299,733 | EPS -$0.05 | |
| DFP HEALTHCARE ACQUISITIONS CORP. (STLN) | 8/16/2021 4:41:15 PM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $49,844,000 | Assets $230,754,006 | EPS $0.05 | |
| DFP HEALTHCARE ACQUISITIONS CORP. (STLN) | 5/28/2021 7:51:25 AM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $48,580,000 | Assets $203,439,000 | EPS -$0.02 | |
| DFP HEALTHCARE ACQUISITIONS CORP. (STLN) | 5/24/2021 6:14:24 AM | Micro | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Assets $65,689,000 | EPS -$0.24 | ||
| DFP HEALTHCARE ACQUISITIONS CORP. (STLN) | 3/30/2021 5:46:02 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $65,689,000 | EPS -$0.24 | ||
| DFP HEALTHCARE ACQUISITIONS CORP. (STLN) | 11/13/2020 4:16:06 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | ||||
| DFP HEALTHCARE ACQUISITIONS CORP. (STLN) | 8/13/2020 4:28:12 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | ||||
| DFP HEALTHCARE ACQUISITIONS CORP. (STLN) | 5/8/2020 4:15:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 |